153 results on '"Creutzberg, Carien L"'
Search Results
2. Sexual health—a topic for cancer patients receiving oncological treatment with palliative intent
3. Adaptive Objective Configuration in Bi-Objective Evolutionary Optimization for Cervical Cancer Brachytherapy Treatment Planning
4. Automated causal inference in application to randomized controlled clinical trials
5. Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II
6. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
7. p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial
8. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts
9. Prediction of recurrence risk in endometrial cancer with multimodal deep learning
10. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
11. Management of conjunctival melanoma with local excision and adjuvant brachytherapy
12. PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancer
13. Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period
14. A sexual rehabilitation intervention for women with gynaecological cancer receiving radiotherapy (SPARC study): design of a multicentre randomized controlled trial
15. Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative
16. QPOLE: A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction
17. Abstract 5695: Deep learning risk prediction model of distant recurrence from H&E endometrial cancer slides
18. Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer
19. International validation of two EORTC questionnaires for assessment of health‐related quality of life for patients with high‐grade non‐Hodgkin lymphoma (QLQ‐NHL‐HG29) and low‐grade non‐Hodgkin lymphoma (QLQ‐NHL‐LG20)
20. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
21. ENdometrial cancer SURvivors’ follow-up carE (ENSURE): Less is more? Evaluating patient satisfaction and cost-effectiveness of a reduced follow-up schedule: study protocol of a randomized controlled trial
22. Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer
23. Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
24. PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System
25. Red Blood Cell Transfusion Practices for Patients With Cervical Cancer Undergoing Radiotherapy
26. Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer
27. HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes
28. Ruthenium plaque radiation therapy for iris and iridociliary melanomas
29. Management of conjunctival melanoma with local excision and adjuvant brachytherapy
30. Implementing clinical practice guidelines: time to assess it
31. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3) : final results of an international, open-label, multicentre, randomised, phase 3 trial
32. Phase 1-3 of the cross-cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ-22
33. Author Correction: Prediction of recurrence risk in endometrial cancer with multimodal deep learning
34. Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
35. Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
36. Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer
37. Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition
38. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
39. Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer
40. Nomograms for Prediction of Outcome With or Without Adjuvant Radiation Therapy for Patients With Endometrial Cancer: A Pooled Analysis of PORTEC-1 and PORTEC-2 Trials
41. Radiation Treatment Affects Chromosome Testing in Uveal Melanoma
42. POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
43. Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
44. Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial.
45. Ruthenium plaque radiation therapy for iris and iridociliary melanomas
46. Image-Guided Adaptive Brachytherapy (IGABT) for Primary Vaginal Cancer: Results of the International Multicenter RetroEMBRAVE Cohort Study.
47. HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes.
48. Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions.
49. Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer.
50. Phase 1-3 of the cross-cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ-22.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.